Eikonizo Therapeutics, Inc. — Form D
Eikonizo Therapeutics, Inc. of BEVERLY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-16. The offering totals $841K, of which $371K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-05-16
- Form: D
- Accession: 0001735756-18-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $841K
- Amount sold: $371K
- Remaining: $470K
- Investors: 1
- Date of first sale: 2018-05-15
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-312582
Issuer
- Name: Eikonizo Therapeutics, Inc.
- CIK: 0001735756
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 996 HALE STREET, BEVERLY, MA, 01915
- Phone: 617-308-4405
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kevin Kinsella | Director | Beverly, MA |
| Janice Kranz | Director | Beverly, MA |
| William Shaw | Director | Grand Cayman, E9 |
| Stacie Weninger | Director | Watertown, MA |
| Janice Kranz | Executive Officer | Beverly, MA |
| William Shaw | Executive Officer | Grand Cayman, E9 |
Other filings by this issuer (1)
More